A reconstituted in vitro clot model for evaluating laser thrombolysis

Abram D. Janis, Lisa A. Buckley, Abby N. Nyara, Scott A. Prahl, Kenton Gregory

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background/objective: Laser thrombolysis is the selective removal of thrombus from occluded blood vessels using laser energy. A reconstituted clot model with reproducible optical absorption properties was developed to evaluate the effect of various laser parameters on thrombus removal rate. Study design/materials and methods: Reconstituted clots were made with known fibrinogen concentrations and hematocrits. Ex vivo clots were collected from ten swine. Four red gelatin phantoms were prepared. Mass removal rates and ablation efficiencies were determined using a 577 nm, 1 μsec pulsed dye laser. The ablation efficiencies of the three clot models were compared at an energy of 25 mJ and a repetition rate of 4 Hz. In addition, the reconstituted clot model was ablated as pulse energy and repetition rate were varied with average power held constant at 100 mW. Results: The mean ablation efficiency for ex vivo clots ranged from 0.4 ± 0.1 to 3.4 ± 0.7 μg/mJ/pulse, with significant differences between groups (ANOVA, p <0.05). Reconstituted clots of varied fibrinogen content had ablation efficiencies of 1.5 ± 0.2 to 1.6 ± 0.3 μg/mJ/pulse at this energy and repetition rate. Gelatin ablation efficiency was inversely proportional to protein content and ranged from 0.5 ± 0.3 to 2.0 ± 0.7 μg/mJ/pulse. Reconstituted clot mass removal rates (in μg/s) were clinically similar for settings ranging from 13 mJ at 8 Hz to 33 mJ at 3 Hz. Conclusions: The reconstituted model clot is a reproducible and biologically relevant thrombolysis target. Ex vivo clot lacks reproducibility between individuals and gelatin phantoms lack clinical relevance. At a constant average power, varying laser parameters did not affect mass removal rates to a clinically significant degree.

Original languageEnglish (US)
Pages (from-to)167-175
Number of pages9
JournalJournal of Thrombosis and Thrombolysis
Volume13
Issue number3
DOIs
StatePublished - Jun 2002

Fingerprint

Lasers
Gelatin
Pulse
Fibrinogen
Thrombosis
Dye Lasers
Hematocrit
Blood Vessels
Analysis of Variance
Swine
In Vitro Techniques
Proteins

Keywords

  • Ablation
  • Mass removal rate
  • Stroke

ASJC Scopus subject areas

  • Hematology
  • Cardiology and Cardiovascular Medicine

Cite this

A reconstituted in vitro clot model for evaluating laser thrombolysis. / Janis, Abram D.; Buckley, Lisa A.; Nyara, Abby N.; Prahl, Scott A.; Gregory, Kenton.

In: Journal of Thrombosis and Thrombolysis, Vol. 13, No. 3, 06.2002, p. 167-175.

Research output: Contribution to journalArticle

Janis, Abram D. ; Buckley, Lisa A. ; Nyara, Abby N. ; Prahl, Scott A. ; Gregory, Kenton. / A reconstituted in vitro clot model for evaluating laser thrombolysis. In: Journal of Thrombosis and Thrombolysis. 2002 ; Vol. 13, No. 3. pp. 167-175.
@article{8d7ebb2d2fc1487680be8cf51a46a07c,
title = "A reconstituted in vitro clot model for evaluating laser thrombolysis",
abstract = "Background/objective: Laser thrombolysis is the selective removal of thrombus from occluded blood vessels using laser energy. A reconstituted clot model with reproducible optical absorption properties was developed to evaluate the effect of various laser parameters on thrombus removal rate. Study design/materials and methods: Reconstituted clots were made with known fibrinogen concentrations and hematocrits. Ex vivo clots were collected from ten swine. Four red gelatin phantoms were prepared. Mass removal rates and ablation efficiencies were determined using a 577 nm, 1 μsec pulsed dye laser. The ablation efficiencies of the three clot models were compared at an energy of 25 mJ and a repetition rate of 4 Hz. In addition, the reconstituted clot model was ablated as pulse energy and repetition rate were varied with average power held constant at 100 mW. Results: The mean ablation efficiency for ex vivo clots ranged from 0.4 ± 0.1 to 3.4 ± 0.7 μg/mJ/pulse, with significant differences between groups (ANOVA, p <0.05). Reconstituted clots of varied fibrinogen content had ablation efficiencies of 1.5 ± 0.2 to 1.6 ± 0.3 μg/mJ/pulse at this energy and repetition rate. Gelatin ablation efficiency was inversely proportional to protein content and ranged from 0.5 ± 0.3 to 2.0 ± 0.7 μg/mJ/pulse. Reconstituted clot mass removal rates (in μg/s) were clinically similar for settings ranging from 13 mJ at 8 Hz to 33 mJ at 3 Hz. Conclusions: The reconstituted model clot is a reproducible and biologically relevant thrombolysis target. Ex vivo clot lacks reproducibility between individuals and gelatin phantoms lack clinical relevance. At a constant average power, varying laser parameters did not affect mass removal rates to a clinically significant degree.",
keywords = "Ablation, Mass removal rate, Stroke",
author = "Janis, {Abram D.} and Buckley, {Lisa A.} and Nyara, {Abby N.} and Prahl, {Scott A.} and Kenton Gregory",
year = "2002",
month = "6",
doi = "10.1023/A:1020431007864",
language = "English (US)",
volume = "13",
pages = "167--175",
journal = "Journal of Thrombosis and Thrombolysis",
issn = "0929-5305",
publisher = "Springer Netherlands",
number = "3",

}

TY - JOUR

T1 - A reconstituted in vitro clot model for evaluating laser thrombolysis

AU - Janis, Abram D.

AU - Buckley, Lisa A.

AU - Nyara, Abby N.

AU - Prahl, Scott A.

AU - Gregory, Kenton

PY - 2002/6

Y1 - 2002/6

N2 - Background/objective: Laser thrombolysis is the selective removal of thrombus from occluded blood vessels using laser energy. A reconstituted clot model with reproducible optical absorption properties was developed to evaluate the effect of various laser parameters on thrombus removal rate. Study design/materials and methods: Reconstituted clots were made with known fibrinogen concentrations and hematocrits. Ex vivo clots were collected from ten swine. Four red gelatin phantoms were prepared. Mass removal rates and ablation efficiencies were determined using a 577 nm, 1 μsec pulsed dye laser. The ablation efficiencies of the three clot models were compared at an energy of 25 mJ and a repetition rate of 4 Hz. In addition, the reconstituted clot model was ablated as pulse energy and repetition rate were varied with average power held constant at 100 mW. Results: The mean ablation efficiency for ex vivo clots ranged from 0.4 ± 0.1 to 3.4 ± 0.7 μg/mJ/pulse, with significant differences between groups (ANOVA, p <0.05). Reconstituted clots of varied fibrinogen content had ablation efficiencies of 1.5 ± 0.2 to 1.6 ± 0.3 μg/mJ/pulse at this energy and repetition rate. Gelatin ablation efficiency was inversely proportional to protein content and ranged from 0.5 ± 0.3 to 2.0 ± 0.7 μg/mJ/pulse. Reconstituted clot mass removal rates (in μg/s) were clinically similar for settings ranging from 13 mJ at 8 Hz to 33 mJ at 3 Hz. Conclusions: The reconstituted model clot is a reproducible and biologically relevant thrombolysis target. Ex vivo clot lacks reproducibility between individuals and gelatin phantoms lack clinical relevance. At a constant average power, varying laser parameters did not affect mass removal rates to a clinically significant degree.

AB - Background/objective: Laser thrombolysis is the selective removal of thrombus from occluded blood vessels using laser energy. A reconstituted clot model with reproducible optical absorption properties was developed to evaluate the effect of various laser parameters on thrombus removal rate. Study design/materials and methods: Reconstituted clots were made with known fibrinogen concentrations and hematocrits. Ex vivo clots were collected from ten swine. Four red gelatin phantoms were prepared. Mass removal rates and ablation efficiencies were determined using a 577 nm, 1 μsec pulsed dye laser. The ablation efficiencies of the three clot models were compared at an energy of 25 mJ and a repetition rate of 4 Hz. In addition, the reconstituted clot model was ablated as pulse energy and repetition rate were varied with average power held constant at 100 mW. Results: The mean ablation efficiency for ex vivo clots ranged from 0.4 ± 0.1 to 3.4 ± 0.7 μg/mJ/pulse, with significant differences between groups (ANOVA, p <0.05). Reconstituted clots of varied fibrinogen content had ablation efficiencies of 1.5 ± 0.2 to 1.6 ± 0.3 μg/mJ/pulse at this energy and repetition rate. Gelatin ablation efficiency was inversely proportional to protein content and ranged from 0.5 ± 0.3 to 2.0 ± 0.7 μg/mJ/pulse. Reconstituted clot mass removal rates (in μg/s) were clinically similar for settings ranging from 13 mJ at 8 Hz to 33 mJ at 3 Hz. Conclusions: The reconstituted model clot is a reproducible and biologically relevant thrombolysis target. Ex vivo clot lacks reproducibility between individuals and gelatin phantoms lack clinical relevance. At a constant average power, varying laser parameters did not affect mass removal rates to a clinically significant degree.

KW - Ablation

KW - Mass removal rate

KW - Stroke

UR - http://www.scopus.com/inward/record.url?scp=0036624418&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036624418&partnerID=8YFLogxK

U2 - 10.1023/A:1020431007864

DO - 10.1023/A:1020431007864

M3 - Article

C2 - 12355034

AN - SCOPUS:0036624418

VL - 13

SP - 167

EP - 175

JO - Journal of Thrombosis and Thrombolysis

JF - Journal of Thrombosis and Thrombolysis

SN - 0929-5305

IS - 3

ER -